Search Within

Jason Konner

Formats
  1. Journal Article (83)
  2. Meeting Abstract (69)
  3. Correspondence (2)
  4. Book Section (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (156)
  2. GDMT, Medicine (156)
  3. Gynecologic Medicine Service (156)
  4. Gynecology Disease Management Team (156)
  5. Solid Tumor Oncology Division (156)
  6. Surgery (59)

More Groups

People
  1. Carol Aghajanian (85)
  2. William Tew (60)
  3. Paul Sabbatini (52)
  4. Martee Hensley (49)
  5. Alexia Iasonos (44)
  6. Roisin O'Cearbhaill (43)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (8)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Gynecologic Oncology (31)
  3. International Journal of Gynecological Cancer (14)
  4. Clinical Cancer Research (13)
  5. Annals of Oncology (9)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. Elsevier Inc. (35)
  3. American Association for Cancer Research (15)
  4. Lippincott Williams & Wilkins (15)
  5. Oxford University Press (11)
  6. Springer (6)

More Publishers

Results (156)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Mesonephric and mesonephric-like carcinomas of the female genital tract: Molecular interrogation including three cases mixed with serous and mucinous neoplasms
    Meeting Abstract

    da Silva, E. M.; Fix, D.; Sebastiao, A. P. M.; Selenica, P.; Lorenzo, F.; Lee, S.; Smith, E.; Stylianou, A.; Da Cruz Paula, A.; Pareja, F.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Mesonephric and mesonephric-like carcinomas of the female genital tract: Molecular interrogation including three cases mixed with serous and mucinous neoplasms
    Meeting Abstract

    da Silva, E. M.; Fix, D.; Sebastiao, A. P. M.; Selenica, P.; Lorenzo, F.; Lee, S.; Smith, E.; Stylianou, A.; Da Cruz Paula, A.; Pareja, F.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
    Journal Article

    Liu, Y. L.; Filippova, O. T.; Zhou, Q.; Iasonos, A.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; Broach, V. A.; O'Cearbhaill, R. E.; more...
    Journal of Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • VATS can be used to effectively triage women with ovarian cancer and moderate to large pleural effusions to PDS or NACT/IDS
    Meeting Abstract

    Filippova, O.; Bharathan, R.; Cowan, R.; Lakhman, Y.; Tew, W.; O'Cearbhaill, R.; Konner, J.; Park, B.; Huang, J.; Gardner, G.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • A phase 2 study of TPIV200/ huFR-1 (a multi-epitope folate receptor alpha vaccine) in combination with durvalumab in patients with platinum resistant ovarian cancer
    Meeting Abstract

    Zamarin, D.; Yeku, O.; O'Cearbhaill, R. E.; Cadoo, K. A.; Gallagher, J.; Kravetz, S.; McDonnell, A.; Troso-Sandoval, T.; Sabbatini, P.; Lichtman, S.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • FORWARD I (GOG 3011): A phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)
    Meeting Abstract

    Moore, K.; Oza, A.; Colombo, N.; Oaknin, A.; Scambia, G.; Lorusso, D.; Farias-Eisner, R.; Banerjee, S.; Murphy, C.; Tanyi, J.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma
    Meeting Abstract

    Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Response to immune checkpoint inhibition and survival in BRCA-associated recurrent ovarian cancer
    Meeting Abstract

    Liu, Y. L.; Boland, J. L.; Cadoo, K. A.; Friedman, C. F.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
    Meeting Abstract

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Filippova, O. T.; Chi, D.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; Broach, V.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save